Longeveron Inc. (LGVN)
NASDAQ: LGVN · Real-Time Price · USD
0.5330
+0.0020 (0.38%)
At close: Jan 21, 2026, 4:00 PM EST
0.5450
+0.0120 (2.25%)
Pre-market: Jan 22, 2026, 4:00 AM EST
Longeveron Market Cap
Longeveron has a market cap or net worth of $11.37 million as of January 22, 2026. Its market cap has decreased by -57.19% in one year.
Market Cap
11.37M
Enterprise Value
3.11M
1-Year Change
-57.19%
Ranking
Category
Stock Price
$0.53
Market Cap Chart
Since the IPO on February 12, 2021, Longeveron's market cap has decreased from $172.48M to $11.37M, a decrease of -93.41%. That is a compound annual growth rate of -42.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 11.33M | 4.94% |
| Dec 31, 2025 | 10.79M | -57.95% |
| Dec 31, 2024 | 25.67M | -24.83% |
| Dec 29, 2023 | 34.15M | -49.55% |
| Dec 30, 2022 | 67.68M | -72.36% |
| Dec 31, 2021 | 244.90M | 41.99% |
| Feb 12, 2021 | 172.48M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curis | 12.52M |
| BioLineRx | 12.38M |
| Edesa Biotech | 12.17M |
| Sensei Biotherapeutics | 12.12M |
| CytoMed Therapeutics | 12.12M |
| Akari Therapeutics, | 12.08M |
| Bolt Biotherapeutics | 12.05M |
| Imunon | 11.77M |